AB InBev Wins Cannes Lions Creative Marketer of the Year for an Unprecedented Third Time

 LONDON - Wednesday, 06. May 2026

The world’s leading brewer’s approach to creativity as a competitive advantage results in strong performance and increased revenues

 

(BUSINESS WIRE)--The Cannes Lions International Festival of Creativity has announced AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD) as the 2026 Creative Marketer of the Year. The honorary accolade is presented to a marketer that has amassed a body of iconic, Lion-winning work over a sustained period of time. AB InBev’s continued commitment to using creativity as a growth lever across its portfolio resulted in it winning an impressive 37 Lions at last year’s Festival.

AB InBev is the first company in Cannes Lions’ history to be honoured with the award for a third time. Since 2021 the global brewer has embarked on a journey of inorganic to organic growth, betting on creativity as a key competitive advantage that has contributed to strong performance and increased revenues.

About the honour, Simon Cook, CEO, LIONS, said: “AB InBev has embedded creativity into how it operates, not just how it leverages marketing, and it is consistently outperforming as a result. By prioritising creativity at a C-suite level and implementing an internal creative effectiveness system, it continues to demonstrate the clear and compelling link between creative excellence and commercial performance. This is a historic win, recognising a company that has made creativity scalable, measurable and sustainable across hundreds of brands globally.”

AB InBev’s published Q1 2026 business results demonstrate strong momentum across its global footprint, achieving all-time high revenues and increased beer volumes. Its focused and consistent consumer-centric strategy builds brands to drive sustainable long-term growth – with 20 “+1 billion-dollar” brands.

About the award, Marcel Marcondes, Global Chief Marketing Officer, AB InBev, said: “Creativity is always in service to driving growth. To be named Creative Marketer of the Year for the third time in the last five years reflects our consistent and sustainable approach to building brands people love. It’s also a credit to the amazing teams and agency partners we have around the world that are delivering all-time high revenues. Cheers to everyone that helped make this history-making recognition possible.”

At Cannes Lions the Juries have consistently recognised AB InBev and last year awarded work from 10 countries across a breadth of 15 different Lion Awards. Additionally, the Global Effie Index ranked AB InBev as the World’s Most Effective Marketer for the fourth year in a row, and in the Kantar BrandZ rankings, AB InBev brands lead the world’s most valuable beer brands, taking eight of the top 10 places, with Corona ranked number one for two years in a row.

AB InBev will open the 2026 Cannes Lions programme, delivering a keynote on the Lumière Theatre stage at 10am, Monday 22 June. Following this, it will be honoured as Creative Marketer of the Year at the final Awards Show of the Festival on Friday 26 June.

Cannes Lions will run from 22 to 26 June in Cannes, France. To view the full programme and see the range of Festival passes available, visit www.canneslions.com.

About LIONS

LIONS is the global platform that champions creativity and marketing effectiveness for growth. We help businesses grow through creative marketing that matters.

We know that creativity can and should be applied across the full marketing mix. Creativity is an impactful business driver - and when it's integrated with a culture of effectiveness, it's a competitive advantage.

Backed by over 150 years of experience and evidence, Cannes Lions, WARC, Effie, Contagious and Acuity - provides the global marketing industry with the definitive benchmarks, intelligence, training and tailored advice needed to grow.

LIONS is part of Informa PLC.

www.lions.co

About Informa

Informa PLC is a leading international B2B events, digital services and academic research group.

We champion specialists. Through hundreds of market-leading brands, we connect people with knowledge so they can learn more, know more and do more.

We operate in over 30 countries and serve businesses and professionals working in over a dozen specialist markets.

Informa is listed on the London Stock Exchange and is a member of the FTSE 100.

www.informa.com

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506536538/en/

Permalink

https://www.aetoswire.com/en/news/6052026548111

Contacts

AB InBev

Media Relations

E-mail: media.relations@ab-inbev.com

Camilla Lambert

PR Director

LIONS

Camillal@canneslions.com

Tash Naidoo

Senior PR Manager

LIONS

Tashn@canneslions.com

Press Portal:

press.canneslions.com

Awards enquiries:

awards@canneslions.com

 

BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates

 Total global revenues of $1.5 billion for the first quarter, an increase of 35% from the prior year

 

Foundational BRUKINSA (zanubrutinib) global revenues of $1.1 billion for the first quarter, an increase of 38% from the prior year

 

Diluted GAAP Earnings per American Depository Share (ADS) of $1.96 for the first quarter; non-GAAP diluted Earnings per ADS of $3.24 for the first quarter

 

(BUSINESS WIRE) -- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the first quarter of 2026.

John V. Oyler, Co-Founder, Chairman, and CEO, BeOne, said:

“These strong first-quarter results reinforce BeOne’s continued growth as a global oncology leader, driven by disciplined commercial execution, and underpinned by our established hematology leadership, and an impressive, rapidly emerging solid tumor pipeline. The sustained competitive advantages of our global superhighway for clinical development and manufacturing are now clear. BRUKINSA has firmly established itself as the foundational, best-in-class BTK inhibitor with unmatched long-term efficacy and safety data for the treatment of CLL and as the only BTKi with proven efficacy superiority over ibrutinib which has resulted in clear global revenue leadership. The fixed-duration combination of sonrotoclax, a foundational, next-generation BCL2 inhibitor, and BRUKINSA represents a potential new standard-of-care in first-line CLL, with BTK CDAC BGB-16673 emerging as a potential first-in-class therapy in the relapsed or refractory setting. With more than 20 abstracts across our hematology and solid tumor pipeline accepted for presentation at ASCO, BeOne has solidified its position as a leading oncology company.”

Product Revenue totaled $1.5 billion for the first quarter of 2026, representing growth of 34% compared to the prior-year period.

BRUKINSA: Global sales totaled $1.1 billion for the first quarter of 2026, representing growth of 38% compared to the prior-year period; U.S. sales of BRUKINSA totaled $761 million in the first quarter of 2026, representing growth of 35% compared to the prior-year period.

TEVIMBRA (tislelizumab): Global sales totaled $206 million in the first quarter of 2026, representing growth of 20% compared to the prior-year period.

Amgen in-licensed products: Global sales totaled $142 million in the first quarter of 2026, representing growth of 25% compared to the prior-year period.

Gross Margin as a percentage of global product sales for the first quarter of 2026 was 89%, compared to 85% in the prior-year period on a GAAP basis. The gross margin percentage increased due to a proportionally higher sales mix of global BRUKINSA compared to other products in our portfolio. Gross margin also benefited from productivity improvements resulting in lower costs for both BRUKINSA and TEVIMBRA.

Research and Development (R&D) Expenses increased for the first quarter of 2026 compared to the prior-year period on both a GAAP and adjusted basis due to advancing preclinical programs into the clinic and early clinical programs into late stage.

Selling, General and Administrative (SG&A) Expenses increased for the first quarter of 2026 compared to the prior-year period on both a GAAP and adjusted basis due to continued investment to support commercial growth. SG&A expenses as a percentage of product sales were 37% for the first quarter of 2026, compared to 41% in the prior-year period.

Net Income and Basic/Diluted Earnings Per Share

GAAP net income for the first quarter of 2026 was $227 million, an increase of $226 million over the prior-year period, primarily attributable to revenue growth and improved operating leverage.

For the first quarter of 2026, basic and diluted earnings per share were $0.16 and $0.15 per share and $2.05 and $1.96 per American Depositary Share (ADS), compared to basic and diluted earnings per share of $0.00 per share and $0.01 per ADS in the prior-year period.

Free Cash Flow for the first quarter of 2026 was $161 million, representing an increase of $173 million over the prior-year period.

For further details on BeOne’s First Quarter 2026 Financial Statements, please see BeOne’s Quarterly Report on Form 10-Q for the first quarter of 2026 filed with the U.S. Securities and Exchange Commission.

Updated Full Year 2026 Guidance

BeOne’s total revenue guidance for full year 2026 of $6.3 billion to $6.5 billion includes expectations for strong revenue growth driven by BRUKINSA’s leadership position in the U.S. and continued global expansion in both Europe and other important rest of world markets. Gross margin percentage is expected to be in the high-80% range and includes the impact of product mix and a full year of 2026 productivity improvements. Guidance for combined operating expenses on a GAAP basis includes expectations of investment to support growth in both commercial and research at a pace that continues to deliver meaningful operating leverage.

The Company is providing the following additional guidance on items impacting net income and earnings per ADS:

Other income (expense): Estimated range of $25 million to $50 million in expense, includes interest amortization from Royalty Pharma arrangement.

Income tax outlook: Earnings may provide sufficient positive evidence to reverse certain valuation allowances in 2026, resulting in a material tax benefit when recognized; the timing and magnitude of a potential reversal is uncertain; prior to reversal, income tax expense should trend with earnings per historical relationship. See Form 10-Q for additional updates on income tax uncertainties.

Diluted ADS outstanding: The Company expects diluted ADSs outstanding of approximately 118 million.

First Quarter 2026 Business Highlights

Core Marketed Products

BRUKINSA (zanubrutinib)

Received Orphan Drug Designation in Japan for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL).

Submitted New Drug Application in Japan for R/R MZL and tablet formulation.

Sonrotoclax (BCL2 inhibitor)

Launched and commercially available in China for the treatment of adult patients with R/R mantle cell lymphoma (MCL) and R/R chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

Included in the European Society of Medical Oncology (ESMO) guidelines as a recommended third-line treatment for R/R MCL patients.

TEVIMBRA (tislelizumab)

Received acceptance of a Supplemental Biologics License Application (sBLA) by the U.S. Food and Drug Administration (FDA) with Priority Review for the treatment of adult patients with first-line HER2-positive gastroesophageal adenocarcinoma (GEA) in combination with ZIIHERA (zanidatamab) and chemotherapy, based on results of the HERIZON-GEA-01 trial which demonstrated statistically significant and clinically meaningful improvement in overall survival versus trastuzumab plus chemotherapy.

Received acceptance of sBLA by the Center for Drug Evaluation (CDE) in China for the treatment of adult patients with first-line HER2-positive GEA in combination with ZIIHERA and chemotherapy.

ZIIHERA (zanidatamab)

Received acceptance of sBLA by the CDE in China for the treatment of adult patients with first-line HER2-positive GEA in combination with chemotherapy, with or without TEVIMBRA.

Select Clinical-Stage Programs

Hematology

BGB-16673 (BTK CDAC): Initiated Phase 2 cohorts in R/R MZL and Richter’s Transformation.

Breast and Gynecological Cancers

BGB-43395 (CDK4 inhibitor): Received acceptance of Phase 1 study data as a poster presentation at ASCO.

BG-C9074 (B7-H4 ADC): Received acceptance of Phase 1 study data as a rapid oral presentation at ASCO.

Gastrointestinal Cancers

BGB-B2033 (GPC3x41BB bispecific antibody):

Received FDA Orphan Drug Designation for hepatocellular carcinoma (HCC).

Initiated potentially registrational study in patients with HCC.

Received acceptance of Phase 1 study data as a rapid oral presentation at ASCO.

Lung Cancer

BG-C0979 (ADAM9-targeting ADC): Initiated first-in-human study.

Inflammation and Immunology

BG-A3004 (KLRG1 mAb): Initiated first-in-human study.

Anticipated R&D Milestones

BeOne’s Earnings Results Webcast

The Company’s earnings conference call for the first quarter 2026 will be broadcast via webcast at 8:00 a.m. ET on Wednesday, May 6, 2026, and will be accessible through the Investors section of BeOne’s website at www.beonemedicines.com. Supplemental information in the form of a slide presentation, transcript of prepared remarks, and a replay of the webcast will also be available.

About BeOne

BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The Company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before.

To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding: BeOne’s continued growth as a global oncology leader; the fixed-duration combination of sonrotoclax and BRUKINSA as a potential new standard-of-care in first-line CLL; the emergence of BGB-16673 as a potential first-in-class therapy for R/R CLL; BeOne’s future revenue, gross margin percentage, operating expenses, operating income, other income or expense, income tax and diluted ADS outstanding; BeOne’s expectations regarding continued global expansion and investment to support growth; upcoming R&D milestones to be achieved by BeOne; the timing of clinical and regulatory developments and data readouts; and BeOne’s plans, commitments, aspirations and goals under the caption “About BeOne.” Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors, including BeOne’s ability to demonstrate the efficacy and safety of its drug candidates; the clinical results for its drug candidates, which may not support further development or marketing approval; actions of regulatory agencies, which may affect the initiation, timing and progress of clinical trials and marketing approval; BeOne’s ability to achieve commercial success for its marketed medicines and drug candidates, if approved; BeOne’s ability to obtain and maintain protection of intellectual property for its medicines and technology; BeOne’s reliance on third parties to conduct drug development, manufacturing, commercialization, and other services; BeOne’s limited experience in obtaining regulatory approvals and commercializing pharmaceutical products; BeOne’s ability to obtain additional funding for operations and to complete the development of its drug candidates and achieve and maintain profitability; and those risks more fully discussed in the section entitled “Risk Factors” in BeOne’s most recent periodic report filed with the U.S. Securities and Exchange Commission (“SEC”), as well as discussions of potential risks, uncertainties, and other important factors in BeOne’s subsequent filings with the SEC. All information in this press release is as of the date of this press release, and BeOne undertakes no duty to update such information unless required by law. BeOne’s financial guidance is based on estimates and assumptions that are subject to significant uncertainties.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506304875/en/

Permalink

https://www.aetoswire.com/en/news/0605202654809

Contacts

Investor Contact

Liza Heapes

+1 857-302-5663

ir@beonemed.com

Media Contact

Kyle Blankenship

+1 667-351-5176

media@beonemed.com

 

Megaport Launches Built-In DDoS Protection Enabling On-Demand Network Resilience

 BRISBANE, Australia - Wednesday, 06. May 2026 AETOSWire 

Megaport DDoS Protection removes the trade-off between security, performance, and cost, offering rapid enterprise-grade mitigation.

 

(BUSINESS WIRE)--Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of Megaport DDoS Protection. This new, built-in security capability for Megaport Internet allows customers to filter malicious traffic directly within the Megaport network rather than routing it through a separate or external service, for mission-critical uptime without introducing additional latency or routing complexity.

As enterprises increasingly migrate to distributed cloud environments, traditional DDoS mitigation has struggled to keep pace with cloud and distributed infrastructure adoption. Standard ISP solutions often resort to dropping all traffic and taking the service offline to protect the network, while external third-party providers force a "security detour" that reroutes traffic through public infrastructure, introducing significant latency and complexity.

Megaport DDoS Protection removes these challenges by integrating fabric-native protection directly into the Megaport network, closing the gap between basic ISP tools and complex enterprise-grade security solutions. By keeping protection inline with the private network path, traffic stays on its intended route without being diverted, maintaining peak performance even while under attack.

"Network resilience is now a core infrastructure requirement, not an optional extra," said Michael Reid, CEO at Megaport. "Moving DDoS protection inside the network layer rather than treating it as a bolt-on service eliminates the traditional trade-offs between security, performance, and cost. It takes users less than a minute to deploy Megaport Internet, and its native DDoS protection works to keep digital services available and high-performing regardless of external threats."

Key features and benefits of Megaport DDoS Protection include:

Fabric-Native Mitigation: Unlike external providers, Megaport filters traffic within its own network, eliminating the need for traffic redirection to external scrubbing centers, reducing latency, and maintaining control.

Rapid Deployment: The capability is fully self-service and can be easily added via the Megaport Portal in under 60 seconds. Users get smarter protection almost instantly thereafter.

Targeted Protection: Mitigation occurs at the host/IP level. Only malicious traffic is filtered while the rest of the network continues to operate normally.

Simplified Pricing: Costs are aligned to connection capacity rather than the size or frequency of attacks, removing the unpredictability of attack-based cost models that are often associated with legacy providers.

Operational Simplicity: Pre-configured protection profiles reduce the need for manual tuning while still distinguishing between legitimate traffic surges and attack patterns.

The service is designed for environments where downtime has immediate financial and brand impact, whether they are handling high-traffic or highly critical processes. Megaport DDoS Protection offers both passive and active mitigation modes, specifically focusing on Layer 3 and Layer 4 attacks.

The launch of DDoS Protection is part of Megaport’s evolution toward owning the full connectivity experience for its customers, providing a platform where performance and protection are managed together as core components of network infrastructure.

For more information, visit http://megaport.com/products/ddos.

About Megaport

Megaport is changing how businesses connect their infrastructure, with one smart and simple platform to manage every connection. Build secure, scalable, and agile networks in just a few clicks, accessing global endpoints and creating private paths in minutes. Trusted by the world’s leading companies, Megaport partners with global service providers, DC operators, systems integrators, and managed services companies, and operates in 1,100+ enabled locations worldwide. Megaport is ISO/IEC 27001 certified. Get connected at megaport.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260505202015/en/

Permalink

https://www.aetoswire.com/en/news/6052026547944

Contacts

Media Enquiries

Adam Hennessy, Senior Director Brand & Communications, Megaport

Phone: +61 7 3088 7400

media@megaport.com

Two Years Running: Ghana Teacher Is Regional Winner in Cambridge Awards

 Judges pick Abigail Agyeiwaa as regional winner out of over 1,500 Sub-Saharan African teachers

Voting now open for global winner

(BUSINESS WIRE) -- Abigail Agyeiwaa has been named the 2026 regional winner of the Cambridge Dedicated Teacher Awards for Sub-Saharan Africa by the International Education group at Cambridge University Press & Assessment (Cambridge). A teacher at Mangoase Senior High School in the Akuapem North Municipality, Abigail was chosen by the judges for her impact on education and wellbeing for young people in her community. Her win follows that of fellow Ghanaian Portia Dzilah, who took the overall global prize last year.

Abigail is one of nine regional winners of the competition that celebrates the achievements of teachers around the world. Abigail began her teaching career in 2014, teaching English at a small school in Adawso. Her work soon became focused on promoting quality rural education and bridging the gap between rural and urban learning opportunities. Her commitment to vulnerable learners led her to establish KAGAS Foundation Ghana, through which she has implemented sustainable programmes in education, health and gender empowerment within the Akuapem North Municipality.

Abigail said. ‘Quality education is a fundamental human right, not a privilege. Teaching for me, has always meant looking beyond the classroom to understand what holds learners back, whether that is poverty, health or opportunity. If removing those barriers helps even one child stay in school, feel valued and believe in their future, then every effort is worth it. This award strengthens my commitment to uplifting others and creating positive change, however small.’

Rod Smith, Group Managing Director of International Education, Cambridge, said, ‘Abigail exemplifies the very highest ideals of the teaching profession. By stepping beyond the classroom to support learners’ health and wellbeing, she has shown how education can be a powerful force for social change. It is teachers like Abigail who make the greatest difference in education, and that commitment is exactly what this award exists to recognise.’

Global winner voting

The public can vote for Abigail, or another of the nine regional winners, to become the overall, global winner at dedicatedteacher.cambridge.org/vote. The deadline for voting is 08:00 (GMT) on 13 May 2026 and the winner will be announced on 02 June 2026.

The 2026 competition received over 12,000 nominations for teachers in 126 different countries.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506176505/en/

Permalink

https://aetoswire.com/en/news/0605202654823

Contacts

Judith Gaskell

International Education, Cambridge University Press & Assessment

judith.gaskell@cambridge.org

 

Hisense Delivers 38% Sales Uplift in Western Europe Markets With NIQ’s AI-Powered Market Intelligence

 CHICAGO -

NIQ insights drive international expansion and measurable growth for Hisense across key global markets

(BUSINESS WIRE)--NIQ (NYSE: NIQ), a global leader in consumer intelligence, today shared new learnings from its long-standing collaboration with Hisense, a leading global brand in home appliances and smart technologies. Using NIQ’s AI‑powered market intelligence, Hisense has accelerated international expansion, improved local market decision-making, and delivered measurable growth across more than 20 key markets and 12+ categories. The case study demonstrates how AI‑driven insights help global brands move faster, localize better, and compete more effectively in complex markets.

The Challenge

As Hisense expanded internationally, it faced rising complexity across global markets. Consumer preferences differed sharply across regions such as Western Europe, Eastern Europe, and Latin America, making a one‑size‑fits‑all approach ineffective.

NIQ’s AI‑powered intelligence delivered the local market depth needed to guide investment, refine product positioning, and identify the features that mattered most in each market. By embedding NIQ insights into day‑to‑day decision‑making, Hisense shifted from retrospective reporting to faster, more proactive action--anticipating demand, aligning inventory with distributors, and adjusting pricing as market conditions evolved.

Key Results for Hisense:

+18% CAGR in overseas revenue including TV and household appliances (2015–2024)

38% year‑on‑year TV value growth in Western Europe (2024)

Stronger competitive positioning across Europe, LATAM, and other growth regions

“For Hisense, our collaboration with NIQ is far more than access to market data—it’s the foundation for building trusted local collaborations and unlocking sustainable growth in key regions,” said Jerry Liu, Chairman, Hisense VIDAA. “NIQ doesn’t just provide numbers, they have become an extension of our team, helping us turn complexity into clarity.”

“Hisense is a strong example of how global brands can use AI‑powered market intelligence to scale with confidence,” said Julian Baldwin, President, Global Strategic Accounts at NIQ. “By combining NIQ’s proprietary data, AI-driven decision systems, and local expertise, Hisense is able to read market signals with greater speed and clarity, act on them with confidence, and turn those signals into measurable growth.”

As Hisense looks ahead, the next phase focuses on deeper AI‑driven foresight to anticipate consumer trends, support sustainability-led innovation, and enable faster, more automated decision making across the business.

This case study reflects NIQ’s broader focus on embedding AI into its core solutions, helping companies move beyond insight generation to decision systems that enable faster, smarter growth at scale.

Learn more about how AI accelerates NIQ’s The Full View™.

Frequently Asked Questions (FAQ)

What is the collaboration between NIQ and Hisense?

NIQ provides Hisense with AI‑powered market intelligence to support it’s global expansion, local market decisions, and long‑term growth. NIQ’s continuous insight ecosystem empowered Hisense to fine-tune pricing, assortment, feature sets, and inventory with speed.

How does NIQ use AI in this partnership?

NIQ uses AI to analyze large volumes of sales and consumer data, identify trends, and deliver faster, more accurate insights to support decision making. NIQ’s AI-powered foresight to anticipate consumer trends, drive smarter product innovation, and enable faster, automated decision-making across the business.

What results has Hisense achieved using NIQ insights?

Hisense delivered +18% overseas revenue CAGR, and 38% YoY TV value growth in Western Europe.

Which regions benefited most from the partnership?

Hisense has global impact across key regions including Western Europe, Eastern Europe, Latin America, and other emerging markets.

What’s next for NIQ and Hisense?

Together, NIQ and Hisense are strengthening their collaboration to unlock deeper AI-driven insights and enable smarter, more predictive decision making across the business.

About NIQ

NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action. With operations in more than 90 countries,

NIQ covers approximately 82% of the world’s population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™—helping brands and retailers understand what consumers buy, why they buy it, and what to do next. For more information, please visit www.niq.com.

Forward Looking Statement:

This press release regarding the collaboration between Hisense and NIQ may contain forward-looking statements regarding anticipated consumer behaviors, market trends, and industry developments. These statements reflect current expectations and projections based on available data, historical patterns, and various assumptions. Words such as " will", “expects,” “anticipates,” “projects,” “believes,” “forecasts,” “plan,” “look ahead,” “indicates”, and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future outcomes and are subject to inherent uncertainties, including changes in consumer preferences, economic conditions, technological advancements, and competitive dynamics. Actual results may differ materially from those expressed or implied in these statements. While we strive to base our insights on reliable data and sound methodologies, we undertake no obligation to update any forward-looking statements to reflect future events or circumstances, except to the extent required by applicable law.

NIQ-GENERAL

© 2026 Nielsen Consumer LLC. All Rights Reserved.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260505610002/en/

Permalink

https://aetoswire.com/en/news/54529007

Contacts

 

Media Contact:

NIQ: media.relations@niq.com

Aircall Acquires Vogent to Advance Its AI Voice Agent Built Natively into Business Phones

 SAN FRANCISCO & PARIS - Wednesday, 06. May 2026 AETOSWire 

 

(BUSINESS WIRE)--Aircall, the AI-powered customer communications platform trusted by more than 22,000 businesses worldwide, today announced the acquisition of Vogent, an AI voice agent company. The acquisition adds a new layer of specialized voice AI technology to Aircall’s platform – strengthening the technology behind Aircall’s AI Voice Agent and moving it from already great to best-in-class.

While AI agents' chat or email based communication channels have exploded in popularity, voice is its own discipline – with unique demands around timing, interruption handling, call flows, and production reliability. Voice channel also comes with the highest expectations from customers, further putting scrutiny around the readiness of the technology. For many businesses deploying AI voice agents, the experience has not lived up to the hype.

With Vogent, Aircall enhances its AI Voice Agents with a deeper set of specialized AI technologies, including advanced speech models, more reliable turn-taking, and higher precision over how AI models behave in those live phone calls. Integrated with Aircall’s easy-to-use platform, growing businesses around the world can deploy voice agents without any specialized technical expertise while still having access to best-in-class voice agents that drive reliable outcomes – more reliable automation on repetitive calls, better customer qualification on inbound opportunities, stronger containment before escalation, and when necessary, seamless hand-off experience to their teams.

Vogent’s San Francisco-based team joins a company accelerating its presence across the US in major tech hubs of San Francisco, Seattle, and New York. Along with its deep European roots, Aircall AI is committed to providing best-in-class AI customer communication services to businesses globally.

“Aircall has always focused on helping teams have better conversations with customers. Our AI Voice Agent helps businesses automate high-volume interactions on the communications platform they trust for voice. With Vogent, we are taking the next step: deepening the AI stack behind that experience with more technology and expertise across voice activity detection, conversational flow routing, custom voice models, and continuous refinement. That is where voice AI becomes truly valuable – not when it is added as a feature by a generalist CX platform, but when it is built by a company that understands voice at its core.” — Scott Chancellor, CEO, Aircall

“At Vogent, we've had one focus: building the most advanced voice AI pipeline on the market. That means custom models throughout the stack, from the voices themselves to turn detection, interruption handling, and latency management, because those are the things that separate a demo from something you can trust on a real customer call. That focus has powered millions of dials for businesses across industries.” — Vignesh Varadarajan, CTO, Vogent

“When we started talking to Aircall, the fit was clear. They had already built a strong AI Voice Agent on top of a platform trusted by 22,000 businesses, and bringing our technology and customers to that platform means the pipeline we've spent years refining can now reach businesses at a scale we couldn't have built toward alone.” — Jagath Vytheeswaran, CEO, Vogent

About Aircall

Aircall is an AI-powered customer communications platform for sales and support teams. The platform helps more than 22,000 businesses collaboratively manage voice, SMS, and WhatsApp conversations, handle high-volume inbound interactions autonomously through AI Voice Agent, automate post-call workflows, and connect every interaction to the tools they already use across 250+ native integrations. Founded in Paris, Aircall serves customer-facing teams globally.

About Vogent

Vogent is an AI voice agent company focused on the core layers that make automated phone conversations work in production. Its platform is designed to help businesses build, test, deploy, maintain, and refine voice AI agents with more natural conversation flow, deeper customization, and stronger operational performance.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260506396746/en/

Permalink

https://www.aetoswire.com/en/news/54526631

Contacts

 

Coltin Kinsey

coltin.kinsey@aircall.io

Novatus Global Receives a King’s Award for Enterprise

 LONDON - Wednesday, 06. May 2026 AETOSWire Print 

(BUSINESS WIRE)--Novatus Global Limited (“Novatus” “Novatus Global” or “the Company”), an award-winning provider of regulatory technology solutions and consulting services to global financial institutions, has been honoured with a King’s Award for Enterprise.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260505378016/en/

Novatus is one of only 185 organisations nationally to be recognised with a prestigious King’s Award for Enterprise in 2026. Announced today (Wednesday 6 May), the Award acknowledges the company’s outstanding achievement in Innovation.

Novatus Global, founded in 2019, employs over 100 people across London, the U.S., Australia, and India and has rapidly established itself as a trusted partner to many of the world’s leading banks, asset managers, and financial institutions. Its flagship product, Novatus En:ACT, is a market-leading SaaS platform delivering complete, real-time assurance across global transaction reporting regimes. The company has cemented its position as an innovation leader, underpinned by strong client adoption and revenues that have more than doubled over the past twelve months.

“We are incredibly proud to receive the King’s Award for Enterprise in Innovation, one of the UK’s highest recognitions for business excellence,” said Matthew Ranson, Co-Founder and Co-CEO of Novatus. “This award is a testament to the extraordinary work of our team in building En:ACT - a platform that is redefining how global financial institutions approach regulatory reporting and of our consulting teams who help transform organisations. It reflects not only the strength of British innovation, but the trust our clients place in us to deliver greater accuracy, transparency, and confidence across the financial system.”

“Winning this award marks a significant milestone in our journey from a two-person start-up to a global technology and consulting business, and we are deeply grateful to His Majesty The King for this recognition,” continued Andrew Hedley, Co-Founder and Co-CEO of Novatus. “It recognises the impact our innovation is having – helping firms move away from costly cycles of failure towards real-time, data-driven assurance that benefits regulators, institutions, and wider society. Most importantly, it is a celebration of our people, whose expertise and ambition continue to drive our growth and deliver meaningful value to our customers.”

The King’s Awards for Enterprise -previously known as The Queen’s Awards for Enterprise -were renamed in 2023 to reflect His Majesty The King’s commitment to continuing the legacy of HM Queen Elizabeth II in celebrating exceptional UK businesses.

Now in its 60th year, the King’s Awards for Enterprise remain the UK’s most prestigious business accolades. Successful organisations may use the esteemed King’s Awards Emblem for the next five years, signalling excellence to customers, partners, and global markets. Applications for the 2027 round will open on 6 May 2026.

Further information is available at: https://www.gov.uk/kings-awards-for-enterprise

About Novatus Global Limited

Novatus Global, established in 2019 and headquartered in London, is a leading global provider of software and strategic consulting services, enabling the world’s largest financial institutions to navigate their most complex regulatory and strategic challenges. Our expertise spans transaction reporting, data & AI, risk, compliance, ESG and strategy & operations,, delivering solutions that drive operational excellence and demonstrable regulatory compliance. Our award-winning SaaS platform, Novatus En:ACT, enables firms to ensure accurate, complete, and timely transaction reporting across all global reporting regimes. Novatus Global pairs cutting-edge technology with unparalleled industry knowledge, ensuring clients meet evolving regulatory demands and mitigate risk effectively. We are trusted by global institutions to meet their mission critical obligations, transform their transaction reporting, streamline operations, and achieve sustainable growth in an increasingly complex regulatory landscape.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260505378016/en/

Permalink

https://www.aetoswire.com/en/news/54529476

Contacts

 

Press:

Andrew Hedley

ahedley@novatus.global